The differentiation antigen NY-BR-1 is a potential target for immunotherapy in breast cancer

MLA

Seil, I., et al. “The Differentiation Antigen NY-BR-1 Is a Potential Target for Immunotherapy in Breast Cancer.” 27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCOP058 /20060320/, 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn761431205&authtype=sso&custid=ns315887.

APA

Seil, I., Frei, C., Engels, K., Sültmann, H., Jäger, E., Zatloukal, K., Knuth, A., Old, L., Chen, Y., Stauber, R., & Jäger, D. (2006). The differentiation antigen NY-BR-1 is a potential target for immunotherapy in breast cancer. 27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCOP058 /20060320/.

Chicago

Seil, I, C Frei, K Engels, H Sültmann, E Jäger, K Zatloukal, A Knuth, et al. 2006. “The Differentiation Antigen NY-BR-1 Is a Potential Target for Immunotherapy in Breast Cancer.” 27. Deutscher Krebskongress; 20060322-20060326; Berlin; DOCOP058 /20060320/. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn761431205&authtype=sso&custid=ns315887.